Needham & Company Raises Estimates on Apple (AAPL), But One Major Risk Remains
Tweet
Share
E-mailGet Alerts AAPL Hot Sheet
Price: $169.02 +1.27%
Rating Summary:
39 Buy, 25 Hold, 7 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
39 Buy, 25 Hold, 7 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Needham & Company maintains a 'Buy' on Apple (NASDAQ: AAPL) price target of $620.00.
Analyst, Charlie Wolf, said, "On stronger than anticipated iPhone sales, Apple delivered another blockbuster quarter. We’re raising our fiscal 2012 estimate from $41.25 to $44.25 and our 2013 estimate from $53.00 to $55.25."
"The major risk we see in the Apple story is that the company may no longer be able to innovate at the same rapid pace or with the same disruption that characterized the Steve Jobs era. However, as Mr. Jobs frequently said near the end of his life, his greatest creation was Apple itself."
For an analyst ratings summary and ratings history on Apple click here. For more ratings news on Apple click here.
Shares of Apple closed at $560.28 yesterday.
Analyst, Charlie Wolf, said, "On stronger than anticipated iPhone sales, Apple delivered another blockbuster quarter. We’re raising our fiscal 2012 estimate from $41.25 to $44.25 and our 2013 estimate from $53.00 to $55.25."
"The major risk we see in the Apple story is that the company may no longer be able to innovate at the same rapid pace or with the same disruption that characterized the Steve Jobs era. However, as Mr. Jobs frequently said near the end of his life, his greatest creation was Apple itself."
For an analyst ratings summary and ratings history on Apple click here. For more ratings news on Apple click here.
Shares of Apple closed at $560.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's June guidance will miss Street estimates - Barclays
- OncoCyte Corp (OCX) PT Raised to $4.25 at Needham
- Boston Scientific (BSX) PT Raised to $83 at Stifel
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Needham & Company, Steve JobsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
